"*IPT: MEDCO ENERGI INTERNASIONAL $BENCHMARK 5NC2 FXD, 9.125%" - BBG
New Issue: $Benchmark 5NC2
Tender: $ 26 and $ 27
IPT: 9.125%
FV: T+464bp area (c. 8.45%)
• Indonesian oil & gas company, PT Medco Energi Internasional, has mandated banks for a new $benchmark deal from wholly owned subsidiary Medco Cypress Tree. The new notes will be unconditionally and irrevocably guaranteed by the parent. Medco is also in the market tendering its $ '26 and $ '27 bonds.
• Medco is predominantly an oil & gas company (91% of revenues) with around 50% of EBITDA derived from fixed-priced gas contracts, which it also guides for 2025. Overall leverage related to the restricted group, the oil & gas businesses only, was 1.8x at end 2024 versus 2.2x in 2023. For 2025 the company guides leverage below 2.5x assuming oil at $65/boe.
• In terms of a fair value estimate, we focus mainly on the existing Medco curve, as well as other HY Indonesian issuers. We see fair value at z+495bp (T+464bp, 8.45%) around 10bp wide to the more seasoned $500m Medco 4/29s.

Find more articles and bullets on these widgets:
ACGBs (YM -12.0 & XM -16.5) are significantly cheaper but at session highs after today’s domestic confidence data.
NAB’s March business survey was little changed from February with confidence down 1 point to -3 and conditions up 1 point to +4. The result is in line with moderate growth but doesn’t signal any pickup in the pace of the recovery, likely given heightened uncertainty. The survey results don’t suggest any worry about a global trade war before US reciprocal tariffs were announced, which were higher than expected.
The AOFM sells A$400mn of the 4.25% 21 June 2034 Green Bond: